Eli Lilly and Company’s Post

View organization page for Eli Lilly and Company, graphic

1,947,137 followers

Published in The New England Journal of Medicine and presented at American Heart Association Scientific Sessions 2024: New findings from a Phase 3 trial evaluating a potential treatment option that reduces the risk of worsening heart failure events in adults with heart failure with preserved ejection fraction (HFpEF) and obesity.

Jason Kragerud, PMP, LEED

MasterClass in Mental Health | Looking for peace? I can help you find it | The Power of Now | Risk-Taker | Light Bender | Scrappy MF | Disney Fanatic | Clintonista | Shoe Dog | Bibliophile | Francophile | Epileptic

4w

Eli Lilly and Company I'm not sure "living" with obesity is ideal. Instead, America should slow down its consumption of unhealthy foods.

To view or add a comment, sign in

Explore topics